来自MSN1 个月
BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thought
The men had either been tested for germline (166), somatic (280), or both types (four) of genetic variants of BRCA1, BRCA2, ATM, CDK12, and PALB2 genes, with a view to starting them on PARP ...
Business Insider India4 年
A breast cancer drug shows promise to change prostate cancer treatment
"We have shown that olaparib, a drug already approved for use in breast and ovarian cancer, can extend the lives of men with advanced prostate who have defects in the genes BRCA1, BRCA2 or ATM and ...